本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acumen Pharmaceuticals, Inc.

2.05
-0.0500-2.38%
盘后2.050.00000.00%16:10 EST
成交量:12.34万
成交额:25.76万
市值:1.24亿
市盈率:-0.93
高:2.15
开:2.13
低:2.02
收:2.10
52周最高:2.46
52周最低:0.8551
股本:6,057.34万
流通股本:3,292.95万
量比:0.78
换手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-2.2064
每股收益(LYR):-1.7051
净资产收益率:-85.93%
总资产收益率:-42.23%
市净率:1.33
市盈率(LYR):-1.20

数据加载中...

公司资料

公司名字:
Acumen Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
1996
员工人数:
61
公司地址:
1210-1220 Washington St.,Suite 210,Newton,Massachusetts,United States
邮编:
02465
电话:
传真:
- -
简介:
Acumen Pharmaceuticals, Inc.于1996年在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,正在开发一种新的疾病改善方法,以针对该公司认为是阿尔茨海默病或AD的关键根本原因。阿尔茨海默病是一种大脑进行性神经退行性疾病,会导致记忆和认知功能丧失,最终导致死亡。

董事

名称
职位
Daniel O'Connell
Chief Executive Officer and Director
George Golumbeski
Chairman of the Board and Director
Derrell Porter
Independent Director
Jeffrey L. Ives
Independent Director
Kimberlee C. Drapki
Independent Director
Laura Stoppel
Independent Director
Nathan B. Fountain
Independent Director

股东

名称
职位
Daniel O'Connell
Chief Executive Officer and Director
Russell Barton
Chief Operating Officer
Matthew Zuga
Chief Financial Officer and Chief Business Officer
Amy Schacterle
Chief Regulatory Officer, Head of Quality
Derek Meisner
Chief Legal Officer
Eric Siemers
Chief Medical Officer
Jim Doherty
President and Chief Development Officer